Trial Information
Treatment Response Evaluation in Patients With Gastrointestinal Stromal Tumor Using PET/CT and DW MRI
Inclusion Criteria:
- Metastatic GIST patients suitable for TKI treatment
- GIST patients pursuing preoperative neoadjuvant TKI treatment
Exclusion Criteria:
- Patients with contraindications to MRI and/or TKI treatment. For patients with renal
failure, CT without intravenous contrast will be performed according to clinical
practice.
- Patients who do not sign the consent paper for any reason or do not accept the study
premises or patients who wish to withdraw for any reason during the study
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Principal Investigator
Mona-Elisabeth Revheim, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Oslo University Hospital, Dept of Nuclear Medicine
Authority:
Norway:National Committee for Medical and Health Research Ethics
Study ID:
REK-2010/2089
NCT ID:
NCT01276483
Start Date:
February 2011
Completion Date:
Related Keywords:
- Soft Tissue Neoplasms
- Gastrointestinal Tract
- GIST
- Response Monitoring
- Functional Magnetic Imaging
- Positron Emission Tomography
- Computer Tomography
- Neoplasms
- Soft Tissue Neoplasms
- Gastrointestinal Stromal Tumors